NeuroXess is a neurotechnology company developing implantable brain–computer interface platforms focused on restoring lost neurological function. The company operates in the invasive BCI domain, targeting direct neural signal acquisition and stimulation to enable high-bandwidth interaction with the brain.

Its technology integrates implantable neural electrodes with signal processing and decoding algorithms to translate brain activity into actionable outputs. The platform is designed to support both neural recording and stimulation, enabling closed-loop interaction for functional restoration.

NeuroXess’s systems are intended for clinical and translational research use, with applications in paralysis, communication disorders, and severe neurological injury. The company positions itself alongside next-generation invasive BCI developers, focusing on medical-grade neural interfaces rather than consumer or wellness applications.